EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

02.06.19

Bogus European Patents Kill Cancer Patients, But EPO Still Has the Audacity to Ride the Wave of World Cancer Day

Posted in Europe, Patents at 12:50 am by Dr. Roy Schestowitz

EPO Cancer support in LinkedIn

Summary: Management of the EPO has no sense of shame; in spite of abundant evidence that it contributes to cancer deaths (through monopoly), it is publicly expressing solidarity with the victims

LAST week we wrote about the European Patent Office (EPO) killing literally poor women who have breast cancer. Years ago we dealt with these ethical problems [1, 2] that disturb EPO insiders, who thought they would be doing what’s morally right when they joined the Office. Less than a day ago the EPO started playing with cancer again when it wrote: “On #WorldCancerDay we want to show the world some of the great minds that are working intensively to find a cure for this dreadful disease. http://bit.ly/2DSez3N Please spread the word!”

Notice and pay attention to what picture they use in there. It’s that same one they used years ago (see above). They’re reusing and recycling their propaganda, much like the U.S. Patent and Trademark Office (USPTO) does on occasions.

“This is not what the patent system was conceived for (e.g. denying access to life-saving cancer treatments).”Philipp Widera, writing in Kluwer Patent Blog, has just recalled what the EPO did regarding “patients with breast cancer” — basically helping to deny them access to life-saving treatment they can afford. To quote Widera: “It all started in May 2017 when Östrogenblocker (in English: “Estrogen Blocker”) had been handed down (docket-no I-2 W 6/17). The case can be regarded as a precursor of the Fulvestrant-decision as it concerned the PI-proceedings mentioned above. The underlying patent protected the use of Fulvestrant in the preparation of a medicament for the treatment of a specific group of patients with breast cancer (i.e. a Swiss-type claim). Based on the Pemetrexed-decision of the German Federal Supreme Court (docket-no X ZR 29/15, also known as Actavis v Eli Lilly), the Court of Appeal made it clear that Swiss-type claims are to be treated in the same way as so-called EPC 2000-claims. Hence Swiss-type claims are to be regarded as purpose-limited product claims (and not method claims).”

It is getting hard to tell, more so these days, if these European Patents are fake and void, as corrupt management at the EPO intentionally rushes/prods examiners to grant, passing the cost (or deaths) to the public. We’ll say more about this in the next couple of articles. Here’s another new example from IP Kat (also yesterday):

The patent EP (UK) 2073862 at issue claims a process for the preparation of a cell composition, comprising the steps of centrifuging whole blood in a separator tube, removing half of the platelet poor plasma from the top and re-suspending the remaining plasma and buffy coat to produce enriched platelet rich plasma (PRP). The claim specifies the type of separator tube and the centrifugal force to be used. In particular the claim specifies that the separator tube is either (1) a glass tube containing thixotropic gel and 0.10 M sodium citrate, or (2) a polyethylene terephthalate separator tube containing a highly thixotropic gel formed by a polymer mixture and anhydrous sodium citrate at 3.5 mg/mL. The inventive concept of the claim was said to reside in the resuspension step, which permits preparation of PRP from whole blood using only one centrifuge step.

Last month, seeing a report about patents on blood and vessels, I joked that one day they would patent every component of the human body, including blood plasma. How far will patent maximalism go and what will be its human toll (casualties)? This is not what the patent system was conceived for (e.g. denying access to life-saving cancer treatments).

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. Microsoft is Not an Open Source Company But Microsoft Bribed and Took Over Many Open Source Authorities (Rivals' Voice Hijacked)

    Free/Open Source software (FOSS) and GNU/Linux are being taken over by Microsoft moles, bought by Microsoft Corporation, and the collective voice of the alternative to Microsoft and Windows is being muzzled (they tell us they "love" us while they're attacking us and sometimes suing us)



  2. Techrights' Interpretation of Koch v EPO: The EPO's Management Still Attacks Staff Representatives

    The EPO hopes to get its victims (of EPO abuse) to not only foot their own bills but also the EPO's



  3. Understanding Thierry Breton: “Mister Cash” Arrives at France Télécom

    The psychological harassment of the France Télécom workforce led the "suicide wave" after Breton had left France Télécom



  4. The Breton-Battistelli Relationship and Breton Hiding His Employment Record at Rothschild & Cie Banque

    EPO scoundrels such as Battistelli are closer to Breton than most people care to realise; Breton is hiding part of his career ahead of today's grilling



  5. A Lot of EPO Staff on Dutch Land Protested (Despite Abusive Threats From Management) and a Strike is Reportedly Next

    EPO management in Rijswijk tried hard to prevent workers from protesting on their free time (lunch break), reaffirming that same old belief that nothing is changing at the EPO and nothing will change without truly disruptive action



  6. IRC Proceedings: Wednesday, November 13, 2019

    IRC logs for Wednesday, November 13, 2019



  7. Links 13/11/2019: Docker Enterprise Bought, WordPress 5.3, Qt 5.12.6 Released

    Links for the day



  8. Rebranding Malware and Spyware as 'Linux' to Dilute the Brand (and the News)

    Signal-to-noise ratio continues to be reduced, as a lot of "Linux" news has nothing to do with GNU/Linux or even with Free software



  9. Understanding Thierry Breton: In the Beginning...

    Career roundup of Thierry Breton, possibly the next EU Commissioner



  10. Startpage Has Been Delisted, But it Ought to be Blacklisted

    Startpage has just warned its fans (I am a former fan) of what Startpage itself covertly became months back



  11. IRC Proceedings: Tuesday, November 12, 2019

    IRC logs for Tuesday, November 12, 2019



  12. Links 12/11/2019: Plasma 5.17.3, More Intel Defects, Bytecode Alliance

    Links for the day



  13. You've Gotta Go When You've Gotta Go

    How most staff of the European Patent Office (EPO) feels these days



  14. Teaser: Thierry Breton and His Disquieting Past

    "The company attracted notoriety and loathing in the UK for its role in assessing disability benefit eligibility."



  15. EPO and EU: People Behind the Faces

    It’s no secret that the EPO breaks the law and European officials have taken no concrete steps to intervene; to make matters worse, potentially new EPO allies may soon be put in charge of the EU Commission



  16. Maintaining the 'Delete Github' page

    "This list really is a starting point, which can hopefully increase awareness about the issue of concern."



  17. Linux Foundation Picking Money

    The dating standards of the Linux Foundation



  18. Microsoft 'Borrows' the Linux Brand

    With help from the likes of the Linux Foundation Microsoft continues to misuse and ‘dilute’ the Linux brand (and registered trademark)



  19. EPO Corruption Compared to Cocaine Scandals in Antwerp

    Days after the Dutch protest discussion is sort of 'uncorked' regarding EPO corruption (published, as usual, in the form of anonymous comments)



  20. SUEPO Showed That the Media Won't Cover EPO Corruption Until Half the Workers March in the Streets

    What ought to have been a central (if not 'the' central) issue of debate in Europe is still being treated as borderline irrelevant or marginal



  21. Meanwhile in California

    News from California is being spun by Microsoft this week, owing to weak journalism that's more like PR than journalism



  22. Privacy-Centric Services and Even Drupal/Acquia Defect to the Camp of Mass Surveillance

    In search of money [pun intended] companies and services that are supposed to respect their customers and users turn out to be doing the opposite; this merits research and public discussions



  23. IRC Proceedings: Monday, November 11, 2019

    IRC logs for Monday, November 11, 2019



  24. Links 12/11/2019: Sparky 2019.11 Special Editions and Twisted 19.10.0 Released

    Links for the day



  25. Microsoft's Abduction of the Voice of Its Opposition Highlights the Urgency of the Movement/Campaign to Delete GitHub

    Microsoft understands that by entrapping FOSS and GNU/Linux inside proprietary software platforms like GitHub and Azure it can utilise the false perception that it somehow speaks on behalf of both (whilst attacking both)



  26. IRC Proceedings: Sunday, November 10, 2019

    IRC logs for Sunday, November 10, 2019



  27. SUEPO Protests Against Management of the European Patent Office Brought Back Discussions About Corruption

    The atmosphere at the second-largest institution in Europe has long been toxic; now it is becoming a lot more visible again and comments highlight the reasons for the cover-up (gross misuse of billions of euros)



  28. Links 11/11/2019: Linux 5.4 RC7, HandBrake 1.3.0 and Analysis of XFCE

    Links for the day



  29. Links 10/11/2019: digiKam 6.4.0, OpenMandriva Lx 4.1 Alpha and OpenZFS Plans

    Links for the day



  30. Video: Dutch Media on EPO Protest

    The new video added by SUEPO on Saturday in order to show Dutch media coverage of last week's protest in The Hague


RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

Recent Posts